Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW685698X in pediatric seasonal allergic rhinitis
NCT00107757Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone in seasonal allergic rhinitis (SAR), sponsored by GSK. Started Mar 2005; status: completed.
02
Drugs
fluticasone
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00107757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00107757.